Intelligent Drug Delivery System with Integrated AI, IoT, and Blockchain

Publication ID: 24-11857769_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Drug Delivery System with Integrated AI, IoT, and Blockchain,” Published Technical Disclosure No. 24-11857769_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857769_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,769.

Summary of the Inventive Concept

The present invention integrates a drive assembly for a drug delivery system with AI, IoT, blockchain, and new materials to create a more efficient, secure, and patient-centric system for delivering fluids into the body.

Background and Problem Solved

The original patent addressed the need for automatic injection devices, but it had limitations in terms of monitoring and controlling the drug delivery process. The present invention solves this problem by integrating AI-powered sensors, IoT-enabled communication modules, and blockchain-based data storage to provide real-time monitoring, secure data storage, and optimized drug delivery.

Detailed Description of the Inventive Concept

The inventive concept comprises a drive assembly with a plunger member and a biasing member, which is integrated with an AI-powered sensor to monitor and control the drug delivery process. The system also includes an IoT-enabled communication module to transmit real-time data on the injection process to a remote monitoring system. Additionally, a blockchain-based data storage module is used to securely store and track patient data and injection records. The system may also utilize new materials with enhanced durability and corrosion resistance for the gear system.

Novelty and Inventive Step

The integration of AI, IoT, blockchain, and new materials with the drive assembly for a drug delivery system is novel and non-obvious compared to the original patent. The inventive concept provides a synergistic combination of technologies that enables real-time monitoring, secure data storage, and optimized drug delivery, which was not possible with the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include different types of sensors, communication modules, or data storage systems. The system may also be adapted for use with different types of drugs or injection devices. Additionally, the inventive concept could be integrated with other technologies, such as machine learning or augmented reality, to further enhance its capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of diabetes management, vaccine delivery, and personalized medicine. The system's ability to provide real-time monitoring and secure data storage makes it an attractive solution for patients and healthcare providers alike.

Field of Art

Medical device engineering, specifically drug delivery systems and injection technologies, with expertise in mechanical design, sensor integration, and patient-focused medical device innovation

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, 3-5 years experience in medical device design, familiar with mechanical actuation systems, sensor technologies, and emerging digital health integration techniques

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies like AI, IoT, and blockchain into existing drug delivery mechanical systems represents a predictable extension of current medical device innovation trends. The core mechanical drive assembly remains fundamentally unchanged, with digital monitoring and data management layers added as complementary technological enhancements. These integrations leverage well-established design principles of modular medical device architectures and represent incremental improvements rather than radical reimaginations of the original injection device concept.

Obvious Combinations & Variations

Source Patent Element
Drive assembly with plunger member and biasing mechanism for moving a stopper within a container
PTD Variation
Adding AI-powered sensor to monitor and control drug delivery process
Obviousness Reasoning
Integrating sensors into medical devices is a known technique for enhancing monitoring and performance, representing a predictable application of existing sensor technologies to improve device functionality
Source Patent Element
Mechanical drive surface with plurality of gears for needle actuation
PTD Variation
Implementing new materials with enhanced durability and corrosion resistance for gear system
Obviousness Reasoning
Material science improvements represent a standard design optimization approach, with finite known solutions for enhancing mechanical component performance
Source Patent Element
Injection device for delivering fluid into patient's body
PTD Variation
Adding IoT-enabled communication module to transmit real-time injection data
Obviousness Reasoning
Digital connectivity for medical devices is a well-established trend, representing a logical extension of existing remote monitoring technologies
Source Patent Element
Mechanical plunger actuation system
PTD Variation
Blockchain-based data storage module for securing patient injection records
Obviousness Reasoning
Secure data management is a predictable enhancement for medical technologies, utilizing established cryptographic and distributed ledger techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857769 and the published technical disclosure, a person of ordinary skill in the art would find the proposed variations obvious and anticipated, specifically the integration of digital monitoring, communication, and data management technologies with a standard mechanical drug delivery drive assembly. The combination represents a straightforward application of known techniques to existing medical device architectures, rendering potential claims to such innovations obvious and non-patentable under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,769
TitleDrive assembly and spacer for drug delivery system
Assignee(s)Becton, Dickinson and Company